Gram-Negative Bacterial Resistance.

Authors

Pranita D Tamma

Published in

The New England journal of medicine. Volume 395. Issue 17. Pages 1728-1743. Oct 29, 2026.

Abstract

The rapid worldwide spread of antimicrobial resistance among gram-negative bacteria is driven by a complex interplay of human, environmental, and health care-associated factors and accelerated by mobile genetic elements that facilitate the dissemination of resistance genes. Resistance in gram-negative bacteria arises primarily through reduced drug entry, active drug efflux, modification of antibiotic targets, and enzymatic drug inactivation, most notably through β-lactamase production. Clinically important resistant pathogens include extended-spectrum β-lactamase-producing Enterobacterales, carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa with difficult-to-treat resistance, and carbapenem-resistant Acinetobacter baumannii. Limited access to effective antibiotics and the continued emergence of resistance to available agents pose substantial challenges to the management of these infections. Appropriate management requires timely and accurate diagnostics, targeted use of newer β-lactam agents, effective source control, and judicious selection of treatment durations.

PMID:
42950203
Bibliographic data and abstract were imported from PubMed on 29 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.